It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BIO’s FA Score shows that 1 FA rating(s) are green while.
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BIO’s TA Score shows that 2 TA indicator(s) are bullish.
BIO (@Medical/Nursing Services) experienced а -1.90% price change this weekfor the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.54%. For the same industry, the average monthly price growth was +0.19%, and the average quarterly price growth was +11.76%.
BIO is expected to report earnings on Feb 12, 2026.
The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
BIO | ||
|---|---|---|
OUTLOOK RATING 1..100 | 61 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 82 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 84 | |
PRICE GROWTH RATING 1..100 | 46 | |
P/E GROWTH RATING 1..100 | 30 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| BIO | FPAG | |
|---|---|---|
| RSI ODDS (%) | N/A | 3 days ago 90% |
| Stochastic ODDS (%) | 3 days ago 69% | 3 days ago 83% |
| Momentum ODDS (%) | 3 days ago 70% | 3 days ago 86% |
| MACD ODDS (%) | 3 days ago 70% | 3 days ago 90% |
| TrendWeek ODDS (%) | 3 days ago 64% | 3 days ago 85% |
| TrendMonth ODDS (%) | 3 days ago 69% | 3 days ago 85% |
| Advances ODDS (%) | 19 days ago 68% | 3 days ago 86% |
| Declines ODDS (%) | 5 days ago 66% | 5 days ago 77% |
| BollingerBands ODDS (%) | 3 days ago 64% | 3 days ago 80% |
| Aroon ODDS (%) | 3 days ago 69% | 3 days ago 85% |
A.I.dvisor indicates that over the last year, BIO has been closely correlated with A. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if BIO jumps, then A could also see price increases.
A.I.dvisor indicates that over the last year, FPAG has been closely correlated with TEL. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if FPAG jumps, then TEL could also see price increases.
| Ticker / NAME | Correlation To FPAG | 1D Price Change % | ||
|---|---|---|---|---|
| FPAG | 100% | +0.54% | ||
| TEL - FPAG | 78% Closely correlated | +0.07% | ||
| NXPI - FPAG | 77% Closely correlated | +0.45% | ||
| ADI - FPAG | 76% Closely correlated | +0.65% | ||
| MAR - FPAG | 74% Closely correlated | +3.31% | ||
| C - FPAG | 73% Closely correlated | +0.59% | ||
More | ||||